benefits of glp-1 therapy and GIP–GLP-1 therapies in diabetes and obesity | Gustavo Monnerat posted on the topic The benefits of GLP-1 drugs
Description
Blood sugar control and type 2 diabetes Tirzepatide received its first FDA approval specifically for type 2 diabetes management, marketed as Mounjaro
Additionally, the panel recommended that payers not include an A1c criterion for PA renewal given oral semaglutides benefits beyond A1c control
10.1210/jc.2016-1143 56
Gorabi, A
PlexusDx has no commercial relationship with Mochi Health or its parent company
Alternating between semaglutide and tirzepatide is an approach some patients and providers explore, though insurance coverage for such protocols can be challenging to navigate
